Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug may prevent kidney damage after heart surgery

NCT ID NCT06487585

Recruiting now Disease control Sponsor: University of Maryland St. Joseph Medical Center Source: ClinicalTrials.gov ↗

First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 16 times

Summary

This study tests whether Angiotensin II, given as the first drug for low blood pressure after heart surgery, can reduce complications like kidney injury and irregular heartbeat. About 100 adults undergoing heart surgery with a heart-lung machine will receive the drug if their blood pressure stays low despite fluids. Researchers will track their health for 28 days to see if this approach improves outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VASODILATORY HYPOTENSION DURING OR AFTER CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Maryland St. Joseph Medical Center

    RECRUITING

    Towson, Maryland, 21204, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

VASODILATORY HYPOTENSION DURING OR AFTER CARDIAC SURGERY VASODILATORY HYPOTENSION DURING OR AFTER CARDIAC SURGERY